@BPIFrance drawers pays tribute to @LoValTech with this short comics from the birth of our revolutionary vaccine within @BioMAP team to the company creation to bring the vaccine to the global population.
Go to read it !
#BD#research#COVID19#lovaltech#nasalvaccine
Today, vaccines against COVID19 have limitations and are ineffective against future variants, including the Eris variant.
LoValTech wants to emphasize the importance of developing a vaccine effective against all COVID19 variants, which would avoid this kind of epidemic.
The LoValTech vaccine targets not only the Spike protein but also the N one. The N protein does not mutate, ensuring LVT vaccine efficacy against all current and future variants.
Needle free vaccines start to come out from the labs!!!❌💉
Mathieu Epardaud brilliantly explains the interest of nasal vaccination !
To find out all about these French advances, don't hesitate to consult the article in Sciences & Vie n°1271 by Kheira Bettayeb 📖
#nasalvaccines
We are very proud and honored to inform you that Isabelle Dimier-Poisson has been conferred the"Chevalier de la Légion d'Honneur" award by the French Prime Minister, Elisabeth Borne.
#nomination#innovation#vaccine#lovaltech#research
LoValTech and @aptar Pharma partnership wins #france2030 program by responding to the i-Demo collaborative project call for the MUCOVAC 2.0 project, supported as part of the "Emerging Infectious Diseases and CBRN Threats" Acceleration Strategy.
#biotech#vaccine#France2030
Retour sur ces deux derniers jours à @VivaTech :
De nombreuses rencontres intéressantes et intéressées par notre projet, 🤝
Des échanges enrichissants avec des professionnels de la Tech et de la Healthtech 🦾